RTW Biotech Opportunities (RTW) Competitors GBX 1.52 -0.01 (-0.33%) (As of 10/4/2024 11:52 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlines RTW vs. DVNO, PMGR, FIPP, TPVE, YOLO, FFWD, JTWO, TEK, VEN2, and LFIShould you be buying RTW Biotech Opportunities stock or one of its competitors? The main competitors of RTW Biotech Opportunities include Develop North (DVNO), Premier Miton Glb Renewables Trust (PMGR), Frontier IP Group (FIPP), Triple Point Income VCT Plc E (TPVE), Yolo Leisure and Technology (YOLO), Fastforward Innovations (FFWD), J2 Acquisition (JTWO), Tekcapital (TEK), Ventus 2 VCT (VEN2), and London Finance & Investment Group (LFI). These companies are all part of the "asset management" industry. RTW Biotech Opportunities vs. Develop North Premier Miton Glb Renewables Trust Frontier IP Group Triple Point Income VCT Plc E Yolo Leisure and Technology Fastforward Innovations J2 Acquisition Tekcapital Ventus 2 VCT London Finance & Investment Group Develop North (LON:DVNO) and RTW Biotech Opportunities (LON:RTW) are both small-cap financial services companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends, analyst recommendations, community ranking and media sentiment. Do institutionals and insiders believe in DVNO or RTW? 3.8% of RTW Biotech Opportunities shares are owned by institutional investors. 19.4% of Develop North shares are owned by company insiders. Comparatively, 16.2% of RTW Biotech Opportunities shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts prefer DVNO or RTW? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Develop North 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/ARTW Biotech Opportunities 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the MarketBeat Community favor DVNO or RTW? RTW Biotech Opportunities received 1 more outperform votes than Develop North when rated by MarketBeat users. CompanyUnderperformOutperformDevelop NorthN/AN/ARTW Biotech OpportunitiesOutperform Votes1100.00% Underperform VotesNo Votes Which has preferable valuation and earnings, DVNO or RTW? RTW Biotech Opportunities has higher revenue and earnings than Develop North. RTW Biotech Opportunities is trading at a lower price-to-earnings ratio than Develop North, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDevelop North£1.13M15.52N/A£0.017,020.00RTW Biotech Opportunities£4.17M1.22£83.19M£0.364.22 Is DVNO or RTW more profitable? RTW Biotech Opportunities has a net margin of 1,994.76% compared to Develop North's net margin of 31.11%. RTW Biotech Opportunities' return on equity of 21.42% beat Develop North's return on equity.Company Net Margins Return on Equity Return on Assets Develop North31.11% 1.22% 1.11% RTW Biotech Opportunities 1,994.76%21.42%-0.47% Does the media refer more to DVNO or RTW? In the previous week, RTW Biotech Opportunities had 4 more articles in the media than Develop North. MarketBeat recorded 4 mentions for RTW Biotech Opportunities and 0 mentions for Develop North. RTW Biotech Opportunities' average media sentiment score of 0.08 beat Develop North's score of 0.00 indicating that RTW Biotech Opportunities is being referred to more favorably in the news media. Company Overall Sentiment Develop North Neutral RTW Biotech Opportunities Neutral Which has more risk and volatility, DVNO or RTW? Develop North has a beta of 0.16, meaning that its stock price is 84% less volatile than the S&P 500. Comparatively, RTW Biotech Opportunities has a beta of 0.6, meaning that its stock price is 40% less volatile than the S&P 500. SummaryRTW Biotech Opportunities beats Develop North on 9 of the 13 factors compared between the two stocks. Ad Crypto 101 MediaNext opportunity for crypto millionsOctober isn't just another month in crypto. It's the launchpad for what could be the most explosive bull run in history. And I've found the rocket fuel… One coin is quietly positioning itself to outperform the entire market. The signs are everywhere…Go here to discover the coin that could define this historic bull run with gains kicking off this mo Get RTW Biotech Opportunities News Delivered to You Automatically Sign up to receive the latest news and ratings for RTW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat are MarkeBeat Followers?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RTW vs. The Competition Export to ExcelMetricRTW Biotech OpportunitiesAsset Management IndustryFinancial SectorLON ExchangeMarket Cap£5.10M£778.89M£3.14B£1.39BDividend YieldN/A6.68%4.54%7.88%P/E Ratio4.22779.99402.371,637.69Price / Sales1.2213,891.092,070.79198,643.04Price / Cash0.3286.4550.0934.59Price / Book0.011.791.492.50Net Income£83.19M£56.86M£404.82M£156.30M7 Day PerformanceN/A-0.05%-0.08%-0.21%1 Month Performance-1.94%0.94%1.07%2.27%1 Year Performance25.41%13.83%17.70%95.87% RTW Biotech Opportunities Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RTWRTW Biotech OpportunitiesN/AGBX 1.52-0.3%N/A+25.6%£5.10M£4.17M4.224,971News CoverageDVNODevelop NorthN/AGBX 78flatN/AN/A£19.48M£1.13M7,800.00N/APMGRPremier Miton Glb Renewables TrustN/AGBX 104.84-3.4%N/A+1.2%£19.12M£7.16M-436.83N/AFIPPFrontier IP GroupN/AGBX 32.70-0.9%N/A-32.0%£18.37M£-1,380,000.00-817.5021TPVETriple Point Income VCT Plc EN/AGBX 62.50flatN/AN/A£18.09M£4.35M781.25N/AYOLOYolo Leisure and TechnologyN/AGBX 18.75+4.5%N/A+0.0%£17.57M£14,000.00-12.502FFWDFastforward InnovationsN/AGBX 8.25flatN/A+0.0%£17.55M£-4,193,000.00-2.50N/AJTWOJ2 AcquisitionN/AGBX 9.40flatN/A+0.0%£15.97M£3.88B-1.97N/ATEKTekcapitalN/AGBX 8flatN/A-42.9%£15.86M£-13,040,000.00160.006News CoverageGap DownVEN2Ventus 2 VCTN/AGBX 42-53.6%N/AN/A£15.82M£9.47M1.98N/AGap DownLFILondon Finance & Investment GroupN/AGBX 48.14-6.5%N/A+41.2%£15.02M£1.69M343.864Gap Down Related Companies and Tools Related Companies: DVNO Alternatives PMGR Alternatives FIPP Alternatives TPVE Alternatives YOLO Alternatives FFWD Alternatives JTWO Alternatives TEK Alternatives VEN2 Alternatives LFI Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (LON:RTW) was last updated on 10/5/2024 by MarketBeat.com Staff From Our PartnersThe panic button has already been pressedIf you missed it, my emergency election broadcast is now available on replay.Porter & Company | SponsoredHow a $200,000 Mistake Unlocked a $118 Billion Gold TreasureThe window of opportunity on this gold stock is closing fast. Once word gets out, it may be too late.Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredAI expert reveals new Nvidia predictionEveryone’s talking about AI right now, but I’ve been talking about it for years. And now I’ve just released...Brownstone Research | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored“A very dark day is coming to America”Wall Street Legend on Economy: "If you knew what I know, you'd be terrified too." Something huge is headed ...InvestorPlace | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredGolden Equation: Volatility = OpportunityWhen the market swings wildly, most investors panic… But it doesn't have to be this way. You see, when t...Prosper Trading Academy | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RTW Biotech Opportunities Please log in to your account or sign up in order to add this asset to your watchlist. Share RTW Biotech Opportunities With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
